Results
|
|
25241.
|
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. [electronic resource] by
- Fossella, F V
- Lippman, S M
- Shin, D M
- Tarassoff, P
- Calayag-Jung, M
- Perez-Soler, R
- Lee, J S
- Murphy, W K
- Glisson, B
- Rivera, E
- Hong, W K
Producer: 19970129
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 15
Availability: No items available.
|
|
|
25242.
|
|
|
|
25243.
|
|
|
|
25244.
|
|
|
|
25245.
|
|
|
|
25246.
|
|
|
|
25247.
|
|
|
|
25248.
|
|
|
|
25249.
|
|
|
|
25250.
|
|
|
|
25251.
|
|
|
|
25252.
|
Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator. [electronic resource] by
- Kauffman, R F
- Bensch, W R
- Roudebush, R E
- Cole, H W
- Bean, J S
- Phillips, D L
- Monroe, A
- Cullinan, G J
- Glasebrook, A L
- Bryant, H U
Producer: 19970210
In:
The Journal of pharmacology and experimental therapeutics vol. 280
Availability: No items available.
|
|
|
25253.
|
|
|
|
25254.
|
|
|
|
25255.
|
|
|
|
25256.
|
|
|
|
25257.
|
|
|
|
25258.
|
|
|
|
25259.
|
|
|
|
25260.
|
|